Mary T Szela insider trades

Open-market stock purchases and sales by Mary T Szela, CEO and President at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Feb 10, 2010.

Track record: 9% of 11 scored buys are up 5% or more since purchase, averaging -19%.

Recent trades

DateStockTradeValue
Oct 5, 2026TLSI TriSalus Life Sciences, IncSold (not open market)$11.8K
Jun 30, 2026ABSI Absci CorpBought$149K
Jun 30, 2026TLSI TriSalus Life Sciences, IncBought (not open market)$15.4K
Jun 4, 2026ABSI Absci CorpBought (not open market)—
Jun 4, 2026ABSI Absci CorpBought (not open market)—
Jun 4, 2026ABSI Absci CorpBought (not open market)—
Jun 4, 2026ABSI Absci CorpBought (not open market)—
Jun 4, 2026KURA Kura Oncology, IncBought (not open market)—
May 15, 2026TLSI TriSalus Life Sciences, IncBought$103K
Mar 17, 2026TLSI TriSalus Life Sciences, IncSold$61.4K
Mar 11, 2026TLSI TriSalus Life Sciences, IncSold$18K
Feb 23, 2026TLSI TriSalus Life Sciences, IncBought$125K
Nov 24, 2025TLSI TriSalus Life Sciences, IncBought (not open market)—
Nov 24, 2025TLSI TriSalus Life Sciences, IncBought (not open market)—
Nov 24, 2025TLSI TriSalus Life Sciences, IncBought (not open market)—

Companies traded

  • TLSI TriSalus Life Sciences, Inc: 10 buys, 2 sales, last Oct 5, 2026
  • ABSI Absci Corp: 1 buy, last Jun 30, 2026
  • KURA Kura Oncology, Inc: other filings, last Jun 4, 2026
  • OMGA Omega Therapeutics, Inc: other filings, last Jun 20, 2024
  • RXDX Prometheus Biosciences, Inc: other filings, last Jun 16, 2023
  • CHRS Coherus BioSciences, Inc: 1 sale, last Jan 11, 2021
  • ALIM Alimera Sciences Inc: other filings, last Jun 18, 2020
  • NVLN Novelion Therapeutics Inc: other filings, last May 9, 2017
  • AEGR Aegerion Pharmaceuticals, Inc: other filings, last Nov 29, 2016
  • RCPT Receptos, Inc: other filings, last Aug 27, 2015
  • ABT Abbott Laboratories: 43 sales, last Dec 14, 2011

Get free alerts when Mary T Szela files a new trade →